发明名称 |
PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTION AND/OR TREATMENT OF DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF DECREASE OR LOSS OF ACTIVITY OF BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED BLOOD COAGULATION FACTOR VIII |
摘要 |
The present invention is based on the discovery that by administering a predetermined dosing regimen of a pharmaceutical composition that comprises a bi-specific antigen-binding molecule that recognizes blood coagulation factor IX and/or activated blood coagulation factor IX and blood coagulation factor X and/or activated blood coagulation factor X, it is possible to more effectively prevent and/or treat a disease that develops or progresses as a result of a decrease or loss of the activity of blood coagulation factor VIII and/or activated blood coagulation factor VIII. |
申请公布号 |
WO2015194233(A1) |
申请公布日期 |
2015.12.23 |
申请号 |
WO2015JP60171 |
申请日期 |
2015.03.31 |
申请人 |
CHUGAI SEIYAKU KABUSHIKI KAISHA |
发明人 |
YONEYAMA, KOICHIRO |
分类号 |
A61K39/395;A61P7/04;C07K16/36;C07K16/46 |
主分类号 |
A61K39/395 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|